MOSCOW (Sputnik) – As many as 94 percent of senior citizens develop antibodies against the coronavirus after being inoculated with Russia’s EpiVacCorona vaccine, the head of the Yekaterinburg department of Russia’s Vector research institute that developed the vaccine said on Wednesday.
Read More
MyPillow CEO Lindell Launching ‘Patriotic’ E-Commerce Platform to ‘Rival’ Amazon
...
